{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:11:43Z","timestamp":1792141903094,"version":"4.4.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["2017\/R\/20"],"award-info":[{"award-number":["2017\/R\/20"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University in Saint Louis","doi-asserted-by":"publisher","award":["R01AG058501-01"],"award-info":[{"award-number":["R01AG058501-01"]}],"id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008097","name":"Edward N. and Della L. Thome Memorial Foundation","doi-asserted-by":"publisher","award":["AG062734"],"award-info":[{"award-number":["AG062734"]}],"id":[{"id":"10.13039\/100008097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.nbd.2022.105630","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T18:44:22Z","timestamp":1642272262000},"page":"105630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Soluble TREM2: Innocent bystander or active player in neurological diseases?"],"prefix":"10.1016","volume":"165","author":[{"given":"Fabia","family":"Filipello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Goldsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih Feng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Locca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste M.","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2022.105630_bb0005","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jalz.2018.05.004","article-title":"Cerebrospinal fluid tau, Abeta, and sTREM2 in former National Football League Players: modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration","volume":"14","author":"Alosco","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2022.105630_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13195-019-0545-5","article-title":"Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers","volume":"11","author":"Ashton","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2022.105630_bb0015","doi-asserted-by":"crossref","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","article-title":"Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2)","volume":"290","author":"Atagi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105630_bb0020","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","article-title":"The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E","volume":"290","author":"Bailey","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105630_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification","volume":"12","author":"Barthelemy","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2022.105630_bb0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/IAI.72.2.937-948.2004","article-title":"Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages","volume":"72","author":"Begum","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.nbd.2022.105630_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0065-230X(08)60361-9","article-title":"Shedding from the cell surface of normal and cancer cells","volume":"32","author":"Black","year":"1980","journal-title":"Adv. Cancer Res."},{"issue":"934","key":"10.1016\/j.nbd.2022.105630_bb0040","first-page":"e7","article-title":"Heterozygous TREM2 mutations in frontotemporal dementia","volume":"35","author":"Borroni","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","article-title":"A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells","volume":"194","author":"Bouchon","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2022.105630_bb0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00401-015-1388-1","article-title":"TREM2 regulates microglial cell activation in response to demyelination in vivo","volume":"129","author":"Cantoni","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2022.105630_bb0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.20022220","article-title":"Impaired differentiation of osteoclasts in TREM-2-deficient individuals","volume":"198","author":"Cella","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2022.105630_bb0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006833","article-title":"Prions","volume":"3","author":"Colby","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"726","key":"10.1016\/j.nbd.2022.105630_bb0075","first-page":"e11","article-title":"Investigating the role of rare heterozygous TREM2 variants in Alzheimer\u2019s disease and frontotemporal dementia","volume":"35","author":"Cuyvers","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0080","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","article-title":"Pattern recognition by TREM-2: binding of anionic ligands","volume":"171","author":"Daws","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-019-0319-3","article-title":"TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers","volume":"14","author":"Del-Aguila","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2022.105630_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau2291","article-title":"The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk","volume":"11","author":"Deming","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0095","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-021-02296-1","article-title":"TREM2 expression in the brain and biological fluids in prion diseases","volume":"141","author":"Diaz-Lucena","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2022.105630_bb0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","article-title":"Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia","volume":"24","author":"Dong","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2022.105630_bb0105","doi-asserted-by":"crossref","first-page":"10065","DOI":"10.1021\/bi00106a001","article-title":"Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins","volume":"30","author":"Ehlers","year":"1991","journal-title":"Biochemistry."},{"key":"10.1016\/j.nbd.2022.105630_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6221","article-title":"Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease","volume":"11","author":"Ewers","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0115","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2022.105630_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2017.09.034","article-title":"ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after histidine 157","volume":"660","author":"Feuerbach","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2022.105630_bib614","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.nbd.2022.105630_bb0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jalz.2016.06.005","article-title":"Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer\u2019s disease","volume":"12","author":"Gispert","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2022.105630_bb0130","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000512","article-title":"CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection","volume":"6","author":"Gisslen","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.nbd.2022.105630_bb0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","article-title":"The role of innate immune genes in Alzheimer\u2019s disease","volume":"34","author":"Griciuc","year":"2021","journal-title":"Curr. Opin. Neurol."},{"issue":"2890","key":"10.1016\/j.nbd.2022.105630_bb0140","first-page":"e1","article-title":"Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family","volume":"34","author":"Guerreiro","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2022.105630_bb0155","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","article-title":"Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12","volume":"177","author":"Hamerman","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189865","article-title":"Alternative splicing regulation of low-frequency genetic variants in exon 2 of TREM2 in Alzheimer\u2019s disease by splicing-based aggregation","volume":"22","author":"Han","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2022.105630_bb0165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2022.105630_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-016-0182-1","article-title":"Cerebrospinal fluid soluble TREM2 in aging and Alzheimer\u2019s disease","volume":"8","author":"Henjum","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2022.105630_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2022.105630_bb0180","doi-asserted-by":"crossref","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0185","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105630_bib611","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s12640-021-00383-5","article-title":"Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study","volume":"39","author":"Hu","year":"2021","journal-title":"Neurotox Res."},{"key":"10.1016\/j.nbd.2022.105630_bb0190","article-title":"Correlations between macrophage\/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis","volume":"7","author":"Ioannides","year":"2021","journal-title":"Mult Scler J Exp Transl Clin."},{"key":"10.1016\/j.nbd.2022.105630_bb0195","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/eji.201141679","article-title":"TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells","volume":"42","author":"Ito","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0200","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2022.105630_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.exger.2019.04.003","article-title":"Exercise as a potential modulator of inflammation in patients with Alzheimer\u2019s disease measured in cerebrospinal fluid and plasma","volume":"121","author":"Jensen","year":"2019","journal-title":"Exp. Gerontol."},{"issue":"217","key":"10.1016\/j.nbd.2022.105630_bb0210","first-page":"e1","article-title":"A rare coding variant in TREM2 increases risk for Alzheimer\u2019s disease in Han Chinese","volume":"42","author":"Jiang","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0215","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","article-title":"Coding variants in TREM2 increase risk for Alzheimer\u2019s disease","volume":"23","author":"Jin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2022.105630_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.45","article-title":"Genome-wide association study of Alzheimer\u2019s disease","volume":"2","author":"Kamboh","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2022.105630_bb0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-4827(73)90500-4","article-title":"Natural shedding of carbohydrate-containing macromolecules from cell surfaces","volume":"79","author":"Kapeller","year":"1973","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2022.105630_bb0235","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1523\/JNEUROSCI.2620-14.2015","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke","volume":"35","author":"Kawabori","year":"2015","journal-title":"J. Neurosci."},{"issue":"1276\u20131290","key":"10.1016\/j.nbd.2022.105630_bb0240","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.nbd.2022.105630_bb0245","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/JLB.2HI0720-463RR","article-title":"Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain","volume":"110","author":"Kiianitsa","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2022.105630_bb0250","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0255","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0260","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.WNL.0000160304.00003.CA","article-title":"The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2","volume":"64","author":"Klunemann","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2022.105630_bb0265","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1038\/s41598-020-72878-8","article-title":"Cerebrospinal fluid sTREM2 in Alzheimer\u2019s disease: comparisons between clinical presentation and AT classification","volume":"10","author":"Knapskog","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2022.105630_bb0270","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20391","article-title":"Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms","volume":"5","author":"Kober","year":"2016","journal-title":"Elife."},{"issue":"3","key":"10.1016\/j.nbd.2022.105630_bb0275","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/alz.12194","article-title":"Functional insights from biophysical study of TREM2 interactions with apoE and Abeta1-42","volume":"17","author":"Kober","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2022.105630_bb0280","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2022.105630_bb0285","doi-asserted-by":"crossref","first-page":"2419 e23","DOI":"10.1016\/j.neurobiolaging.2014.04.010","article-title":"Homozygous TREM2 mutation in a family with atypical frontotemporal dementia","volume":"35","author":"Le Ber","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fneur.2020.00062","article-title":"Increased CSF soluble TREM2 concentration in patients with Neurosyphilis","volume":"11","author":"Li","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2022.105630_bb0295","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899456","article-title":"Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments","volume":"37","author":"Lichtenthaler","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2022.105630_bb0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuint.2006.04.002","article-title":"Microglia and the control of autoreactive T cell responses","volume":"49","author":"Melchior","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2022.105630_bb0305","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1212\/WNL.0000000000012257","article-title":"Association of Aortic Stiffness with Biomarkers of Neuroinflammation, synaptic dysfunction, and neurodegeneration","volume":"97","author":"Moore","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2022.105630_bb0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1083\/jcb.200808080","article-title":"TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria","volume":"184","author":"N\u2019Diaye","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2022.105630_bb0315","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1177\/1352458515624558","article-title":"Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone","volume":"22","author":"Ohrfelt","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2022.105630_bb0320","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ana.25691","article-title":"CHIT1 at diagnosis reflects long-term multiple sclerosis disease activity","volume":"87","author":"Oldoni","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2022.105630_bb0325","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2022.105630_bb0330","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","article-title":"TREM2 and beta-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis","volume":"188","author":"Otero","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0335","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/77153","article-title":"Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts","volume":"25","author":"Paloneva","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2022.105630_bb0340","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.56.11.1552","article-title":"CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts","volume":"56","author":"Paloneva","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2022.105630_bb0345","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2022.105630_bb0350","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20030027","article-title":"DAP12\/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features","volume":"198","author":"Paloneva","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0355","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12974-020-01774-9","article-title":"Transcriptomic profiling of microglia and astrocytes throughout aging","volume":"17","author":"Pan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2022.105630_bb0360","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2013.02.003","article-title":"Structure, expression pattern and biological activity of molecular complex TREM-2\/DAP12","volume":"74","author":"Paradowska-Gorycka","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0365","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/tra.12264","article-title":"Disease-associated mutations of TREM2 Alter the processing of N-linked oligosaccharides in the Golgi apparatus","volume":"16","author":"Park","year":"2015","journal-title":"Traffic."},{"key":"10.1016\/j.nbd.2022.105630_bb0370","doi-asserted-by":"crossref","first-page":"13050","DOI":"10.1038\/s41598-021-92101-6","article-title":"The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer\u2019s disease","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2022.105630_bb0375","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0380","doi-asserted-by":"crossref","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","article-title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3","author":"Peng","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2022.105630_bb0385","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12031-019-01424-7","article-title":"Analysis of cerebrospinal fluid soluble TREM2 and polymorphisms in sporadic Parkinson\u2019s disease in a Chinese population","volume":"70","author":"Peng","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2022.105630_bb0390","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/eji.200636837","article-title":"Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis","volume":"37","author":"Piccio","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0395","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2022.105630_bb0400","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2022.105630_bb0405","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1172\/JCI77983","article-title":"TREM2 sustains microglial expansion during aging and response to demyelination","volume":"125","author":"Poliani","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2022.105630_bb0410","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","article-title":"Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition","volume":"17","author":"Price","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2022.105630_bb0415","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2018.10.022","article-title":"CSF soluble TREM2 as a measure of immune response along the Alzheimer\u2019s disease continuum","volume":"74","author":"Rauchmann","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0420","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3233\/JAD-191120","article-title":"Soluble TREM2 and inflammatory proteins in Alzheimer\u2019s disease cerebrospinal fluid","volume":"73","author":"Rauchmann","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2022.105630_bb0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2022.105630_bb0430","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0435","doi-asserted-by":"crossref","first-page":"200 e13","DOI":"10.1016\/j.neurobiolaging.2016.02.024","article-title":"Assessment of the genetic variance of late-onset Alzheimer\u2019s disease","volume":"41","author":"Ridge","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0440","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2018.08.009","article-title":"Inflammatory markers of CHMP2B-mediated frontotemporal dementia","volume":"324","author":"Roos","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2022.105630_bb0445","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2022.105630_bb0450","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000571","article-title":"African Americans have differences in CSF soluble TREM2 and associated genetic variants","volume":"7","author":"Schindler","year":"2021","journal-title":"Neurol Genet."},{"key":"10.1016\/j.nbd.2022.105630_bb0455","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.15252\/emmm.201707672","article-title":"An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function","volume":"9","author":"Schlepckow","year":"2017","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0460","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0465","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.2002.01243.x","article-title":"Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia","volume":"83","author":"Schmid","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105630_bb0470","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","article-title":"Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation","volume":"13","author":"Song","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2022.105630_bb0475","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0480","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp.74.6.825-a","article-title":"An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene","volume":"74","author":"Soragna","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2022.105630_bib612","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","article-title":"Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study","volume":"16","author":"Stokholm","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2022.105630_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1767","article-title":"Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury","volume":"8","author":"Suarez-Calvet","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0490","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers","volume":"8","author":"Suarez-Calvet","year":"2016","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0495","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809712","article-title":"CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline","volume":"10","author":"Suarez-Calvet","year":"2018","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-beta pathology","volume":"14","author":"Suarez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.nbd.2022.105630_bb0505","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.str.2021.06.010","article-title":"Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain","volume":"29","author":"Szykowska","year":"2021","journal-title":"Structure."},{"key":"10.1016\/j.nbd.2022.105630_bb0510","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0520","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.15252\/emmm.201707673","article-title":"TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant","volume":"9","author":"Thornton","year":"2017","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0525","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J. Immunol."},{"issue":"649\u2013663","key":"10.1016\/j.nbd.2022.105630_bb0530","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.nbd.2022.105630_bb0535","doi-asserted-by":"crossref","first-page":"158 e1","DOI":"10.1016\/j.neurobiolaging.2021.02.024","article-title":"CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia","volume":"103","author":"van der Ende","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105630_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100631","article-title":"Wild-type sTREM2 blocks Abeta aggregation and neurotoxicity, but the Alzheimer\u2019s R47H mutant increases Abeta aggregation","volume":"296","author":"Vilalta","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105630_bb0545","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/JLB.MR0818-319R","article-title":"Microglia in Alzheimer\u2019s disease: a target for immunotherapy","volume":"106","author":"Wang","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2022.105630_bb0550","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.nbd.2022.105630_bb0555","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0560","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awaa021","article-title":"Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau","volume":"143","author":"Wilson","year":"2020","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2022.105630_bb0565","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13195-018-0405-8","article-title":"Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup","volume":"10","author":"Woollacott","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2022.105630_bb0570","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000506282","article-title":"Cerebrospinal fluid YKL-40 and Chitotriosidase levels in frontotemporal dementia vary by clinical, genetic and pathological subtype","volume":"49","author":"Woollacott","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2022.105630_bb0575","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20141732","article-title":"TREM-2 promotes macrophage survival and lung disease after respiratory viral infection","volume":"212","author":"Wu","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0580","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","article-title":"Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage","volume":"288","author":"Wunderlich","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105630_bb0585","first-page":"89","article-title":"The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective","volume":"5","author":"Xing","year":"2015","journal-title":"Res Rep Biochem."},{"key":"10.1016\/j.nbd.2022.105630_bb0590","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","article-title":"TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease","volume":"17","author":"Yang","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2022.105630_bb0595","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-Beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron."},{"issue":"1023\u20131031","key":"10.1016\/j.nbd.2022.105630_bb0600","article-title":"TREM2 is a receptor for beta-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2022.105630_bb0605","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival","volume":"214","author":"Zhong","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2022.105630_bb0610","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","article-title":"Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:29:32Z","timestamp":1760851772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996122000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":125,"alternative-id":["S0969996122000213"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105630","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble TREM2: Innocent bystander or active player in neurological diseases?","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105630"}}